Table 2.

Clinical Characteristics of the Study Population

Characteristics	HC n=60	Ps n=100	MetS n=100	Ps+MetS n=80
Gender
Male (%)	31(51.7)	68(68)	67(67)	58(72.6)
Female (%)	29(48.3)	32(32)	33(33)	22(27.4)
Age (M ± SD)	47 ± 14.75	41.33 ± 12.51	61.19 ± 12.51	43.65 ± 14.52
Biochemical index (M ± SD)
LDL (mmol/L)	2.45 ± 0.66	2.73 ± 0.73	2.53 ± 0.89	2.89 ± 1.23*
HDL (mmol/L)	1.25 ± 0.30	1.17 ± 0.30	1.11 ± 0.28**	1.17 ± 0.31
CHO (mmol/L)	4.23 ± 0.81	4.45 ± 0.93	4.21 ± 1.10	4.69 ± 0.99*
TG (mmol/L)	1.18 ± 0.47	1.60 ± 1.10**	1.51 ± 0.97	2.25 ± 1.48***###
BG (mmol/L)	4.94 ± 0.75	5.05 ± 0.79	7.05 ± 2.27***###	5.57 ± 1.89*
Cr (μmol/L)	61.35±13.67	65.32 ± 15.81	78.56 ± 25.6***###	65.11 ± 13.75
UA (μmol/L)	324.85±99.314.00	391.76±102.63***	349.98±114.98##	387.42±125.43**
BUN(mmol/L)	± 1.09	4.51 ± 1.43	6.96 ± 2.37***###	4.04 ± 1.31

Notes: *P< 0.05, **P< 0.01, ***P< 0.01, compared to HC. ^##P< 0.01, ^###P< 0.01, compared to Ps.

Abbreviations: HC, healthy volunteers; Ps, psoriasis; MetS, metabolic syndrome; Ps+MetS, psoriasis with metabolic syndrome.